ER
Erasca
ERAS·NASDAQSan Diego CAFounded 2018130 employees
Small CapbiotechPublicOncology
Platform: RAS/MAPK
Market Cap
$0.7B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (ERAS)
Loading ERAS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datocilimab | ERA-6642 | Approved | 2 | FLT3 | Cervical CaCTCL | ||
| Elraratamab | ERA-1392 | Phase 1 | 1 | PCSK9 | Hemophilia AEndometrial Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)